SUSQUEHANNA INTERNATIONAL GROUP, LLP - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 73 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$118,000
-19.2%
36,993
+8.3%
0.00%
Q1 2022$146,000
-63.1%
34,146
-59.9%
0.00%
Q4 2021$396,000
+238.5%
85,164
+189.7%
0.00%
Q3 2021$117,000
-62.5%
29,400
-59.7%
0.00%
Q2 2021$312,000
-9.0%
73,022
-9.8%
0.00%
Q1 2021$343,000
-48.0%
80,997
-52.4%
0.00%
Q4 2020$660,000
+33.6%
170,120
+38.9%
0.00%
Q3 2020$494,000
+12.8%
122,501
+19.2%
0.00%
Q2 2020$438,0000.0%102,791
-1.5%
0.00%
Q1 2020$438,000
-32.3%
104,338
-36.6%
0.00%
Q4 2019$647,000
-46.3%
164,675
+20.3%
0.00%
Q3 2019$1,204,000
-83.6%
136,885
-82.7%
0.00%
Q2 2019$7,326,000
+1135.4%
792,000
+758.1%
0.00%
Q1 2019$593,000
-1.0%
92,299
+45.2%
0.00%
Q4 2018$599,000
-81.5%
63,550
-60.4%
0.00%
-100.0%
Q3 2018$3,231,000
+47.5%
160,500
+113.6%
0.00%
Q2 2018$2,191,000
-65.7%
75,127
-65.0%
0.00%
-100.0%
Q1 2018$6,385,000
-18.4%
214,422
-11.8%
0.00%0.0%
Q4 2017$7,823,000
-79.1%
243,100
-77.4%
0.00%
-86.7%
Q3 2017$37,359,000
+618.7%
1,074,139
+515.1%
0.02%
+650.0%
Q2 2017$5,198,000
+37.1%
174,626
+37.5%
0.00%0.0%
Q1 2017$3,791,000
+68.1%
127,000
-1.3%
0.00%
+100.0%
Q4 2016$2,255,000
-10.4%
128,646
+21.5%
0.00%0.0%
Q3 2016$2,518,000
+49.3%
105,840
+0.4%
0.00%
Q2 2016$1,687,000
-6.6%
105,423
+22.0%
0.00%
-100.0%
Q1 2016$1,806,000
-6.9%
86,400
+20.2%
0.00%
Q4 2015$1,940,000
-45.3%
71,859
-43.7%
0.00%
-100.0%
Q3 2015$3,547,000
+22.0%
127,644
+7.6%
0.00%
+100.0%
Q2 2015$2,907,000
+74.4%
118,600
+30.3%
0.00%0.0%
Q1 2015$1,667,00091,0530.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2016
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders